Study of MK-1697 in Participants With Advanced Solid Tumors (MK-1697-001)

NCT03515824 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

22

Enrollment

INDUSTRY

Sponsor class

Stopped Business Reasons

Conditions

Neoplasms
Colorectal Neoplasms
Head and Neck Neoplasms

Interventions

BIOLOGICAL: MK-1697

Sponsor

Merck Sharp & Dohme LLC